While both Cvac and Stimuvax target MUC-1, they have at least one key difference. Cvac is a personalised vaccine (like Dendreon's Provenge), whereas Stimuvax is an off-the-shelf product. Personalised vaccines are believed to work better.
The link below provides a thorough analysis into the Stimuvax trials to date (the reader comments on the article are enlightening as well). I do hope that the Stimuvax phase 3 trial is successful, however there is a real possibility that it may not be. If it fails, then I hope that the market realises that that does not mean that Cvac will automatically be a failure as well. Cvac's technology is different and its phase 2 results, I believe, offer a better likelihood of success.
http://www.thestreet.com/story/11179526/1/oncothyreon-deep-dive-into-stimuvax.html
- Forums
- ASX - By Stock
- IMM
- cvac and stimuvax - some perspective.
cvac and stimuvax - some perspective.
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $508.4M |
Open | High | Low | Value | Volume |
35.0¢ | 36.0¢ | 34.5¢ | $503.0K | 1.421M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
48 | 154338 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 348968 | 51 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
55 | 152897 | 0.350 |
18 | 216590 | 0.345 |
11 | 95028 | 0.340 |
8 | 85392 | 0.335 |
5 | 120201 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 341694 | 51 |
0.360 | 254262 | 18 |
0.365 | 106632 | 9 |
0.370 | 146406 | 8 |
0.375 | 148400 | 5 |
Last trade - 15.21pm 19/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |